[email protected]
CAS 62025-49-4 Ginsenoside F2 molecular structure lightbox
CAS RN: 62025-49-4

Ginsenoside F2

Product Availability

Choose a grade to view its available package options.

5 package records4 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250511 5mg / 25mg / 100mg / 500mg Confirm by inquiry Shanghai, Shandong, Guangdong Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250327 100mg In stock Shanghai Inquiry
Batchno.20250810 1g Out of stock Inquiry
Batchno.20250813 250mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250621 20mg In stock Shanghai, Chongqing, Hebei Inquiry
  • Product code: ICTG0581
  • Purity/Analytical Methods: >95.0%(HPLC)
GET A QUOTE

62025-49-4 / (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

Standard CAS: 62025-49-4 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
62025-49-4
Multi CAS
Yes
Molecular Formula
C42H72O13
Molecular Weight
785.000000
Exact Mass
784.497292
InChI
InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,55-37-35(51)33(49)31(47)25(20-44)53-37)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1
InChIKey
SWIROVJVGRGSPO-JBVRGBGGSA-N

Computed Properties

Structural Parameters

Heavy atom count
55
Fraction Csp3
0.95
Rotatable bonds
10
H-bond acceptors
13
H-bond donors
9
Molar refractivity
200.95
TPSA
218.99

LogP / Solubility

WLOGP
2.15
MLOGP
1.96
XLogP3
4
Consensus LogP
2.7
Log S (ESOL)
-5.4
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.55
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.75
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-5.98

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Customers Also Viewed

Get In Touch

Contact Us